Lessons from next generation influenza vaccines for inflammatory disease therapies

Research output: Contribution to journalReview article

Abstract

Lessons can be learned for treating inflammatory diseases such as rheumatoid arthritis (RA) from next generation approaches for development of universal influenza vaccines. Immunomodulation of inflammatory diseases, rather than ablation of cytokine or cellular responses, can address the root cause of the disease and provide potential cure. Like influenza, there are different antigenic ‘strains’ and inflammatory T cell responses, Th1 or Th17, that drive each person's disease. As such, next generation vaccine-like antigen specific therapies for inflammatory diseases can be developed but will need to be customized to the patient depending upon the antigen and T cell response that is driving the disease.

Original languageEnglish (US)
Article number105729
JournalInternational Immunopharmacology
Volume74
DOIs
StatePublished - Sep 2019
Externally publishedYes

Fingerprint

Influenza Vaccines
Therapeutics
T-Lymphocytes
Antigens
Immunomodulation
Human Influenza
Rheumatoid Arthritis
Vaccines
Cytokines

Keywords

  • Immunomodulation
  • Influenza
  • Rheumatoid arthritis
  • T cells
  • Vaccine therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Lessons from next generation influenza vaccines for inflammatory disease therapies. / Zimmerman, Daniel H.; Carambula, R. E.; Ciemielewski, J.; Rosenthal, K. S.

In: International Immunopharmacology, Vol. 74, 105729, 09.2019.

Research output: Contribution to journalReview article

Zimmerman, Daniel H. ; Carambula, R. E. ; Ciemielewski, J. ; Rosenthal, K. S. / Lessons from next generation influenza vaccines for inflammatory disease therapies. In: International Immunopharmacology. 2019 ; Vol. 74.
@article{3e6a4e34333f4d91a73b270f641fafdd,
title = "Lessons from next generation influenza vaccines for inflammatory disease therapies",
abstract = "Lessons can be learned for treating inflammatory diseases such as rheumatoid arthritis (RA) from next generation approaches for development of universal influenza vaccines. Immunomodulation of inflammatory diseases, rather than ablation of cytokine or cellular responses, can address the root cause of the disease and provide potential cure. Like influenza, there are different antigenic ‘strains’ and inflammatory T cell responses, Th1 or Th17, that drive each person's disease. As such, next generation vaccine-like antigen specific therapies for inflammatory diseases can be developed but will need to be customized to the patient depending upon the antigen and T cell response that is driving the disease.",
keywords = "Immunomodulation, Influenza, Rheumatoid arthritis, T cells, Vaccine therapy",
author = "Zimmerman, {Daniel H.} and Carambula, {R. E.} and J. Ciemielewski and Rosenthal, {K. S.}",
year = "2019",
month = "9",
doi = "10.1016/j.intimp.2019.105729",
language = "English (US)",
volume = "74",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",

}

TY - JOUR

T1 - Lessons from next generation influenza vaccines for inflammatory disease therapies

AU - Zimmerman, Daniel H.

AU - Carambula, R. E.

AU - Ciemielewski, J.

AU - Rosenthal, K. S.

PY - 2019/9

Y1 - 2019/9

N2 - Lessons can be learned for treating inflammatory diseases such as rheumatoid arthritis (RA) from next generation approaches for development of universal influenza vaccines. Immunomodulation of inflammatory diseases, rather than ablation of cytokine or cellular responses, can address the root cause of the disease and provide potential cure. Like influenza, there are different antigenic ‘strains’ and inflammatory T cell responses, Th1 or Th17, that drive each person's disease. As such, next generation vaccine-like antigen specific therapies for inflammatory diseases can be developed but will need to be customized to the patient depending upon the antigen and T cell response that is driving the disease.

AB - Lessons can be learned for treating inflammatory diseases such as rheumatoid arthritis (RA) from next generation approaches for development of universal influenza vaccines. Immunomodulation of inflammatory diseases, rather than ablation of cytokine or cellular responses, can address the root cause of the disease and provide potential cure. Like influenza, there are different antigenic ‘strains’ and inflammatory T cell responses, Th1 or Th17, that drive each person's disease. As such, next generation vaccine-like antigen specific therapies for inflammatory diseases can be developed but will need to be customized to the patient depending upon the antigen and T cell response that is driving the disease.

KW - Immunomodulation

KW - Influenza

KW - Rheumatoid arthritis

KW - T cells

KW - Vaccine therapy

UR - http://www.scopus.com/inward/record.url?scp=85068269443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068269443&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2019.105729

DO - 10.1016/j.intimp.2019.105729

M3 - Review article

C2 - 31280056

AN - SCOPUS:85068269443

VL - 74

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

M1 - 105729

ER -